Treatments for parkinson s. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Substantia Nigra Lewy Bodies Dopaminergic Neurons Subthalamic Nucleus Putamen Neurons Pedunculopontine Tegmental Nucleus Brain Corpus Striatum Globus Pallidus Mesencephalon Mitochondria Basal Ganglia Neostriatum Inclusion Bodies PC12 Cells Caudate Nucleus

Diseases31

Parkinson Disease Parkinsonian Disorders Parkinson Disease, Secondary Multiple System Atrophy Lewy Body Disease Neurodegenerative Diseases MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Essential Tremor REM Sleep Behavior Disorder Gaucher Disease Nerve Degeneration Hypokinesia Dementia Movement Disorders Genetic Predisposition to Disease Dyskinesias Olfaction Disorders Disease Models, Animal Alzheimer Disease Sleep Arousal Disorders Primary Dysautonomias Postmortem Changes Manganese Poisoning Dyskinesia, Drug-Induced Pure Autonomic Failure Deglutition Disorders Sweat Gland Diseases Parkinson Disease, Postencephalitic Disease Progression

Chemicals and Drugs53

alpha-Synuclein Antiparkinson Agents Levodopa Glucosylceramidase Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Oxidopamine Ubiquitin-Protein Ligases Oncogene Proteins Tyrosine 3-Monooxygenase Pergolide Carbidopa beta-Synuclein Maneb Neuroprotective Agents 1-Methyl-4-phenylpyridinium Synucleins Tropanes Dopamine Plasma Membrane Transport Proteins Dopamine Agents Dopamine Agonists Benzothiazoles tau Proteins Rotenone Adrenergic Agents Paraquat Apomorphine Amyloid Sympatholytics Nerve Tissue Proteins Pemoline Selenoprotein W Receptors, Dopamine 3,4-Dihydroxyphenylacetic Acid Intracellular Signaling Peptides and Proteins Protein-Serine-Threonine Kinases Chromogranin B Vesicular Monoamine Transport Proteins Cysteinyldopa Proteasome Endopeptidase Complex Ubiquitin Sodium Benzoate Dihydroxyphenylalanine Protein Kinases Selegiline Electron Transport Complex I Fungicides, Industrial Herbicides Thiazoles Amyloid beta-Peptides Glial Cell Line-Derived Neurotrophic Factor Neurotoxins Monoamine Oxidase

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Deep Brain Stimulation Dance Therapy Gait Severity of Illness Index Disease Models, Animal Case-Control Studies Positron-Emission Tomography Genetic Testing Genome-Wide Association Study Neurologic Examination Stereotaxic Techniques DNA Mutational Analysis Reproducibility of Results Analysis of Variance Models, Biological Cohort Studies Exercise Therapy Risk Factors Autopsy Disability Evaluation

Psychiatry and Psychology18

Lewy Body Disease Dance Therapy REM Sleep Behavior Disorder Dementia Neuropsychological Tests Apathy Alzheimer Disease Sleep Arousal Disorders Cognition Disorders Dreams Reality Therapy Motor Skills Introversion (Psychology)Mental Status Schedule Impulse Control Disorders Task Performance and Analysis Psychomotor Performance Motor Activity

Phenomena and Processes17

Postural Balance Gait Genetic Predisposition to Disease Mutation Autophagy Oxidative Stress Polymorphism, Single Nucleotide Penetrance Mutation, Missense Mitochondrial Degradation DNA Repeat Expansion Movement Proteolysis Genotype Psychomotor Performance Motor Activity Time Factors

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena1

Health Care11

Age of Onset Severity of Illness Index Case-Control Studies Genetic Testing Genome-Wide Association Study Accidental Falls Reproducibility of Results Analysis of Variance Cohort Studies Risk Factors Family Health

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Health Care Geographicals

Parkinson Disease alpha-Synuclein Antiparkinson Agents Parkinsonian Disorders Parkinson Disease, Secondary Levodopa Glucosylceramidase Substantia Nigra Lewy Bodies Deep Brain Stimulation Multiple System Atrophy Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Dopaminergic Neurons Oxidopamine Subthalamic Nucleus Lewy Body Disease Neurodegenerative Diseases MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Postural Balance Dance Therapy Putamen Essential Tremor Ubiquitin-Protein Ligases Neurons Pedunculopontine Tegmental Nucleus Brain REM Sleep Behavior Disorder Oncogene Proteins Gaucher Disease Tyrosine 3-Monooxygenase Pergolide Gait Carbidopa Nerve Degeneration beta-Synuclein Hypokinesia Corpus Striatum Dementia Globus Pallidus Movement Disorders Mesencephalon Genetic Predisposition to Disease Age of Onset Mutation Maneb Neuroprotective Agents Mitochondria Dyskinesias 1-Methyl-4-phenylpyridinium Severity of Illness Index Olfaction Disorders Neuropsychological Tests Synucleins Tropanes Dopamine Plasma Membrane Transport Proteins Disease Models, Animal Dopamine Agents Case-Control Studies Dopamine Agonists Apathy Positron-Emission Tomography Alzheimer Disease Benzothiazoles Sleep Arousal Disorders Autophagy tau Proteins Primary Dysautonomias Rotenone Adrenergic Agents Genetic Testing Postmortem Changes Cognition Disorders Basal Ganglia Manganese Poisoning Dyskinesia, Drug-Induced Pure Autonomic Failure Genome-Wide Association Study Paraquat Apomorphine Amyloid Neurologic Examination Sympatholytics Nerve Tissue Proteins Pemoline Selenoprotein W Oxidative Stress Dreams Stereotaxic Techniques Polymorphism, Single Nucleotide Receptors, Dopamine 3,4-Dihydroxyphenylacetic Acid Reality Therapy Motor Skills Deglutition Disorders Intracellular Signaling Peptides and Proteins Sweat Gland Diseases Penetrance

No FAQ available that match "treatments for parkinson s"